Catheter Precision, Inc. (VTAK)
AMEX AMEX Primary Summary
VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.
New York, NY, Feb. 17, 2026, – PRISM MediaWire (Press Release Service – Press Release Distribution) – Creatd, Inc. (OTCQB: CRTD) announced that Catheter Precision, Inc. (NYSE American: VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder.
Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC
FORT MILL, SC / ACCESSWIRE / January 15, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has entered into a definitive agreement to acquire PeriKard, LLC., in a transaction involving the issuance of restricted VTAK common stock for 100% of the LLC interests in PeriKard.
Catheter Precision, Inc. Announces Initial LockeT Purchase From the University of Tennessee Medical Center
FORT MILL, SC / ACCESSWIRE / January 13, 2025 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced it has received its first purchase order for LockeT from the southeast region. As previously announced, the company has recently expanded its US sales and clinical team in preparation for the national product launch of LockeT.
Catheter Precision, Inc. (VTAK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Catheter Precision, Inc. ever had a stock split?
Catheter Precision, Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | David A. Jenkins CEO | AMEX Exchange | 74933X708 CUSIP |
| US Country | 22 Employees | 17 Nov 2020 Last Dividend | 15 Aug 2025 Last Split | 27 Sep 2018 IPO Date |
Overview
Catheter Precision, Inc., initially known as Ra Medical Systems, Inc., is a pioneer in the field of electrophysiology products, focusing on enhancing the quality of life for patients suffering from cardiac arrhythmias across the United States. With its main operations based in Fort Mill, South Carolina, Catheter Precision, Inc. is at the forefront of developing and supplying advanced technologies and solutions tailored for patients, hospitals, and physicians alike. The rebranding to Catheter Precision, Inc. in August 2023 signifies a focus on its core competencies in catheter-based medical technologies. Through its innovative approaches and dedication to healthcare advancements, the company is playing a crucial role in the management and treatment of cardiac arrhythmias.
Products and Services
- View into Ventricular Onset System
- LockeT
- Amigo Remote Catheter System
This non-invasive imaging system represents a breakthrough in the diagnosis and treatment of idiopathic ventricular arrhythmias, particularly for patients with structurally normal hearts. The View into Ventricular Onset System utilizes 3D cardiac mapping technology, assisting physicians in precisely localizing the sites of origin of ventricular arrhythmias before undergoing Electrophysiology (EP) procedures. This advanced diagnostic tool fundamentally enhances the pre-procedure planning, offering a novel approach to cardiac care.
LockeT is an innovative suture retention device designed to improve clinical outcomes for patients requiring catheter-based interventions. This device is engineered to secure catheters in place, effectively minimizing the risk of displacement and potential complications associated with catheter movement. The introduction of LockeT in the market underscores Catheter Precision, Inc.'s commitment to not only diagnostic solutions but also to procedural safety and efficiency.
The Amigo Remote Catheter System incorporates robotic technology in the form of a robotic arm, which acts as a catheter control device. This system is crafted to provide physicians with unprecedented control and precision during catheter manipulation, enhancing the accuracy and safety of catheter-based cardiac procedures. By facilitating remote control of catheters, Amigo serves as a cornerstone in the evolution of minimally invasive cardiac interventions, reinforcing Catheter Precision, Inc.'s role in pioneering medical technology innovation.
